Drug Pipeline

MCLA-129 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 1/2
3
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT04930432 Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced… Solid Tumor Recruiting
NCT07448116 Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors. Solid Advanced Tumor Recruiting
NCT04868877 Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody… Non-Small Cell Lung Cancer Metastatic Active, Not Recruiting
Sponsors Running MCLA-129 Trials
Betta Pharmaceuticals Co., Ltd. (2) Merus B.V. (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2) Colorectal Cancer (2) Head & Neck Cancer (2) Gastric Cancer (1)
Get alerts when MCLA-129 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free